Zynerba Press Releases

5 Dec 16 Zynerba Reports Positive Results for ZYN002 CBD Gel in Phase 1 Studies at 70th Annual Meeting of the American Epilepsy Society

28 Nov 16 Zynerba Pharmaceuticals to Highlight Data for ZYN002 CBD Gel at the 70th Annual Meeting of the American Epilepsy Society

21 Nov 16 Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences

14 Nov 16 Zynerba Pharmaceuticals Reports Third Quarter 2016 Financial Results and Operational Highlights

9 Nov 16 Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences

2 Nov 16 Zynerba Pharmaceuticals Announces Initiation of STAR 2 Open-Label Extension Clinical Trial for ZYN002 CBD Gel in Adult Refractory Epilepsy Patients

17 Oct 16 Zynerba Provides Clinical Update for Lead Development Candidates – ZYN001 and ZYN002

13 Sep 16 Zynerba Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer

6 Sep 16 Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences

6 Sep 16 Zynerba Pharmaceuticals Launches Phase 2 Clinical Trial of ZYN002 CBD Gel for Treatment of Osteoarthritis